Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2007 by National Cancer Institute (NCI).
Recruitment status was Recruiting

Study NCT00301990 Information provided by National Cancer Institute (NCI)

First Received on March 10, 2006. Last Updated on August 11, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Kidney Cancer

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

aldesleukin
bevacizumab

More general drug interventions related to this trial

Sponsors listed in this trial